This study examined the effect of supplementation of a bioavailable source of silicon (sodium zeolite A) on altering systemic markers of bone metabolism in horses. Twenty yearlings (ten Quarter Horses and ten Arabians) were randomly grouped as silicon (Si) supplemented (S; n=10), in which yearlings consumed 2% of the total diet as a Si-containing supplement, and a second non-supplemented control group (C; n=10). Blood samples were taken on days 0, 15, 30 and 45. Both plasma and serum were collected; the plasma was analyzed for Si concentrations and serum was analyzed for osteocalcin (OC), carboxy-terminal pyridinoline cross-linked telopeptide region of type I collagen (ICTP), and pyridinoline and deoxypyridinoline crosslinks (PYD). Supplemented yearlings had higher plasma Si concentrations than C yearlings by day 15, and remained higher than C yearlings on days 30 and 45 (P < 0.0001 for all days). There were no differences between treatment groups for OC or PYD concentrations (P > .05); however, ICTP concentrations were lower in S yearlings on day 45 when compared to C yearlings (P = .04). Results indicate that sodium zeolite A supplementation (consumed at 2% of the total diet) increases plasma Si concentrations. Furthermore, results indicate that Si-supplemented yearlings may have decreased bone resorption, which may provide for greater net bone formations, as OC concentrations were not different between groups. Unfortunately, systemic markers give no indication as to the quality of the bone that may be formed, and further research in the area of Si supplementation, bone metabolism and bone strength is required to establish conclusive evidence as to the benefits of supplemental Si to the skeletal system.